http://rdf.ncbi.nlm.nih.gov/pubchem/reference/26233812

Outgoing Links

Predicate Object
contentType Comparative Study|Evaluation Study|Journal Article|Research Support, Non-U.S. Gov't
endingPage 638
issn 1949-2553
issueIdentifier 7
pageRange 628-638
publicationName Oncotarget
startingPage 628
bibliographicCitation Powe DG, Voss MJ, Zänker KS, Habashy HO, Green AR, Ellis IO, Entschladen F. Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival. Oncotarget. 2010 Nov;1(7):628–38. PMID: 21317458; PMCID: PMC3248123.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_172d2edfc1722a2aa988e89405bc8843
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cffce610280428b38d0c20c4ac7ce789
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_15f9d374336f0dbf38c27de923ad5042
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dc03da793952a4f7f4bb050233f4ab99
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5cea601041168a64e7bede11d9c3206d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6736a855b2f4591694ac9083ccdf4684
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_945f98a89a5a7879bac54fe595bd8b3c
date 2010-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.18632/oncotarget.197
https://doi.org/10.18632/oncotarget.101009
https://pubmed.ncbi.nlm.nih.gov/21317458
https://pubmed.ncbi.nlm.nih.gov/PMC3248123
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37803
https://portal.issn.org/resource/ISSN/1949-2553
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Beta-Blocker Drug Therapy Reduces Secondary Cancer Formation in Breast Cancer and Improves Cancer Specific Survival
discusses http://id.nlm.nih.gov/mesh/M0000495
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D009364Q000517
http://id.nlm.nih.gov/mesh/D006973Q000188
http://id.nlm.nih.gov/mesh/D002277Q000188
http://id.nlm.nih.gov/mesh/D000319Q000627
http://id.nlm.nih.gov/mesh/D001943Q000188
hasSubjectTerm http://id.nlm.nih.gov/mesh/D015536Q000187
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D006973Q000150
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D002277Q000473
http://id.nlm.nih.gov/mesh/D009362
http://id.nlm.nih.gov/mesh/D002277Q000401
http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D000319Q000494
http://id.nlm.nih.gov/mesh/D016896
http://id.nlm.nih.gov/mesh/D016019
http://id.nlm.nih.gov/mesh/D005500
http://id.nlm.nih.gov/mesh/D001943Q000473
http://id.nlm.nih.gov/mesh/D001943Q000401
http://id.nlm.nih.gov/mesh/D001943Q000150
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D002277Q000150
http://id.nlm.nih.gov/mesh/D018572
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4946
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439260
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8102

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127443804
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128645717
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127952853
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129228530
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128590515

Total number of triples: 62.